Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Takeda building

Takeda acquire Maverick in $525m deal to expand cancer therapy portfolio

March 10, 2021 Research and Development Maverick, Takeda, cancer treatment

Takeda has acquired Maverick Therapeutics in a deal worth up to $525 million, in order to expand its portfolio of …
News
evonik__chemie_foto_001

Evonik and Cassava Sciences enter supply agreement for Alzheimer’s drug candidate

March 10, 2021 Research and Development Alzheimer's, Cassava Sciences, Evonik

Evonik has entered into an agreement to supply Cassava Sciences with large-scale, clinical-grade quantities of simufilam, a drug candidate for …
News

Affinivax receives $22m funding for development of Staphylococcus aureus vaccine

March 10, 2021 Research and Development Affinivax, bacteria, vaccines

Affinivax has received an award of $22 million funding from CARB-X, a global non-profit organisation, to develop a vaccine targeting Staphylococcus …
News
COVID-19 virus

Pharmafile.com’s weekly COVID-19 news round-up

March 3, 2021 Research and Development

The past week has continued to see positive COVID-19 news; COVAX has delivered their first batch of vaccines to Africa, …
News

ViaCyte and Gore collaborate on new diabetes treatments

March 3, 2021 Research and Development Type 1 diabetes, diabetes, diabetes treatment, gore, viacyte

Clinical stage medicine company ViaCyte have extended their collaboration with materials science organisation Gore to develop new candidates for the …
News
abbvie

AbbVie funds Mitokinin’s Parkinson’s research with option to buy

March 3, 2021 Research and Development AbbVie, Mitokinin, Parkinson's

AbbVie has landed an option to buy neurodegenerative disease-focused biotech Mitokinin following completion of investigational new drug (IND)-enabling studies on …
News
mavenclad

NHS England increases access to cladribine tablets for multiple sclerosis patients during pandemic

March 3, 2021 Research and Development Cladribine, Mavenclad, Merck, multiple sclerosis

NHS England has updated the Blueteq requirements for patients with highly active relapsing MS starting Merck’s cladribine (Mavenclad) tablets during …
News
astrazeneca_plaque

AstraZeneca wins US court ruling on Symbicort patent claims

March 3, 2021 Research and Development AstraZeneca, Symbicort, law

A US district court has ruled in favour of AstraZeneca in litigation against Mylan Pharmaceuticals and Kindeva Drug Delivery, AstraZeneca …
News

Verona Pharma appoints Novartis Gene Therapies VP Lisa Deschamps to its board

March 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Novartis, verona, verona pharma

Verona Pharma has appointed Lisa Deschamps, Senior Vice President and Chief Business Officer of Novartis Gene Therapies, as Non-Executive Director …
Appointment
sophie_biguenet_cmo_abivax

Abivax appoints Dr Sophie Biguenet as Chief Medical Officer

March 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinical-stage biotechnology company Abivax has appointed Dr Sophie Biguenet as Chief Medical Officer. Dr Biguenet brings 25 years of experience …
Appointment
cov

MAPs during a global pandemic

February 26, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, MAPS

Early and managed access programmes provide opportunities for patients to get the treatments they need faster – but the COVID-19 …
Feature

How COVID-19 has changed pharmacovigilance

February 26, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing COVID-19, pharmacovigilance

The race to provide vaccines and treatments for coronavirus has seen a number of COVID-19 drugs reach the market in …
Feature

UC San Diego School of Medicine researchers treat atopic dermatitis with bacteriotherapy

February 24, 2021 Research and Development atopic dermatitis, eczema

Researchers at the University of California San Diego School of Medicine have identified a universal strain of bacteria derived from …
News

Sanofi and SIRION collaborate on AAV vector development to treat serious diseases

February 24, 2021 Research and Development AAV vectors, SIRION, Sanofi

SIRION Biotech and Sanofi have entered into an agreement to develop effective medicines for illnesses impacting major human organs.
News
cervical dysplasia

QIAGEN and INOVIO to develop diagnostic tests for cervical dysplasia treatment

February 24, 2021 Research and Development Inovio, Qiagen, cervical dysplasia

QIAGEN and INOVIO Pharmaceuticals have extended their collaboration to develop a new diagnostic test which identifies the women most likely …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025